Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Released May 11, 2026, after the close
10-Q filed May 11, 2026, 41 days after period end · 0001628280-26-033417
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$12.51M | -$11.10M | -$5.02M | -$5.17M |
| EPS Diluted | -$0.32 | -$0.28 | -$0.18 | -$1.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2026 · filed May 11, 2026 · 41 d after period end
6.8% from the close of May 11, 2026 to the close of May 13, 2026, the first after the release.
